ID   NCC-LMS3-C1
AC   CVCL_D4A9
DR   Wikidata; Q127382931
RX   PubMed=37907774;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 19 hours (PubMed=37907774).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=37907774
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 5,6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
RX   PubMed=37907774; DOI=10.1007/s13577-023-00991-7;
RA   Yoshimatsu Y., Noguchi R., Osaki J., Sin Y., Tsuchiya R., Ono T.,
RA   Akiyama T., Adachi Y., Tanzawa Y., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-LMS3-C1: a novel
RT   patient-derived cell line of leiomyosarcoma.";
RL   Hum. Cell 37:337-344(2024).
//